Marleen I. Meyers, MD

  • Specialties: Solid Tumors, Oncology
  • Language: English

About Me

Conditions and Treatments

breast cancer

Credentials

Positions
  • Assistant Professor, Department of Medicine
  • Dir Perlmutter Cancer Cent Survivorship Program
Board Certifications
  • American Board of Internal Medicine (Medical Oncology), 1985
  • American Board of Internal Medicine - Internal Medicine, 1982
Education and Training
  • Fellowship, Memorial Hospital for Cancer & Allied Diseases, Oncology, 1985
  • Residency, NYU Medical Center, Medicine, 1983
  • MD from New York University, 1979
Departments

Locations and Appointments

40 Insurance Plans Accepted
  • Aetna HMO
  • Aetna Indemnity
  • Aetna Medicare
  • Aetna POS
  • Aetna PPO/EPO
  • Affinity
  • Affinity Exchange- Essential
  • Cigna EPO/POS
  • Cigna PPO
  • ElderPlan
  • Empire Blue Cross Blue Shield EPO
  • Empire Blue Cross Blue Shield HMO
  • Empire Blue Cross Blue Shield Indemnity
  • Empire Blue Cross Blue Shield MediBlue
  • Empire Blue Cross Blue Shield POS
  • Empire Blue Cross Blue Shield PPO
  • Empire Blue Cross Blue Shield Pathways, Enhanced
  • GHI CBP
  • HealthPlus Child Health (Amerigroup)
  • HealthPlus Family Health (Amerigroup)
  • HealthPlus Medicaid (Amerigroup)
  • HealthSmart (WTC)
  • Humana Medicare
  • Medicare
  • MultiPlan/PHCS PPO
  • NYS Empire Plan
  • Oxford Exchange
  • Oxford Freedom
  • Oxford Liberty
  • Oxford Medicare
  • UPN Elite
  • United Exchange- Compass
  • UnitedHealthcare Community & State Plan
  • UnitedHealthcare EPO
  • UnitedHealthcare HMO
  • UnitedHealthcare Medicare
  • UnitedHealthcare POS
  • UnitedHealthcare PPO
  • UnitedHealthcare Top Tier
  • Visiting Nurse Service (VNS) Medicare
*Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have been changed.
NYU Medical Oncology Associates

160 East 34th Street
New York, NY 10016

Contact

Phone: 212-731-5348

Welcome back!

As a returning patient for this doctor, please schedule an appointment using your MyChart at NYU Langone account.

Learn more about MyChart at NYU Langone.

My Research

Publications

  • RAD001-carboplatin combination in triple-negative metastatic breast cancer (TNMBC): A phase II trial [Meeting Abstract]

    Singh, J C; Stein, S; Volm, M; Smith, J A; Adams, S; Meyers, M; Speyer, J L; Novik, Y; Schneider, R; Formenti, S; Muggia, F; Jhaveri, K L; Goldberg, J D; Heese, S; Li, X; Davis, S; Tiersten, A
    Journal of clinical oncology. 2013 20 May. 31 (15):

  • Phase II trial of RAD001 plus carboplatin in patients with triple-negative metastatic breast cancer [Meeting Abstract]

    Singh, J C; Stein, S; Volm, M; Smith, J A; Novik, Y; Speyer, J L; Meyers, M; Adams, S; Omene, C O; Muggia, F; Schneider, R; Formenti, S; Davis, S; Beardslee, B; Tiersten, A
    Journal of clinical oncology. 2012 20 May. 30 (15):

  • Efficacy of RAD001/carboplatin in triple-negative metastatic breast cancer: A phase II study [Meeting Abstract]

    Singh, J C; Volm, M; Novik, Y; Speyer, J L; Adams, S; Omene, C O; Meyers, M I; Smith, J A; Schneider, R; Formenti, S; Goldberg, J D; Li, X; Davis, S; Beardslee, B; Tiersten, A
    Journal of clinical oncology. 2012 20 Sep. 30 (27):

Read All Publications (13)